Q1: How do you manage non-specific toxicity in cellular assays?

We address this by running parallel cytotoxicity assays, such as LDH release or ATP quantification, in all functional studies. This ensures that observed phenotypic changes are attributable to specific biological mechanisms rather than general cellular damage.

Q2: Can I request a custom phosphorylation assay for a novel kinase target?

Yes, we provide tailored assay development. Our expertise includes creating custom cell models, using CRISPR editing or stable overexpression, to engineer novel target systems. This enables the establishment of specific Western blot, ELISA, or multiplexed assays to measure the activation state of your target.

In Vitro Cellular & Signaling Investigation Services

Background Service Service Packages Workflow Highlights FAQs Contact

Effective drug development requires moving beyond simple target binding to understand a compound's functional impact on cellular signaling pathways. Creative Biolabs' In Vitro Cellular & Signaling Investigation Services provide a comprehensive suite of quantitative assays, including phosphorylation analysis, PARP inhibition studies, immune cell profiling, and safety evaluations like phospholipidosis and RBC agglutination testing. We deliver precise, mechanism-driven insights using advanced technologies such as high-content imaging and multiplex detection. Our tailored, physiologically relevant approach clarifies mechanism of action (MOA), de-risks novel targets, and accelerates your therapeutic development from discovery to preclinical validation.

Introduction

Multidrug resistance (MDR) severely compromises the efficacy of chemotherapy, primarily attributed to mechanisms such as ABC transporter-mediated drug efflux, detoxification processes, and dysregulation of cellular survival pathways. Therefore, developing new agents or utilizing specific antibody-based drugs to reverse MDR holds considerable promise. To systematically evaluate these therapeutic candidates, advanced in vitro assays are essential to analyze drug-cell interactions, transporter activity, cell death pathways, and key signaling cascades. Such experimental platforms are critical for validating mechanisms of resistance reversal and accelerating the advancement of promising candidates into clinical development.

Fig.1 Drug Resistance Pathways in Cancer. (OA Literature) Fig.1 Mechanisms of chemotherapeutic drug resistance in cancer cells. ¹

In Vitro Cellular & Signaling Investigation Services at Creative Biolabs

Creative Biolabs' In Vitro Cellular & Signaling Investigation Services deliver precise, quantitative analysis of how compounds modulate intracellular communication. We provide deep mechanistic insights into therapeutic candidates, from target validation to safety assessment. Utilizing advanced platforms and multiplexed detection, we convert molecular engagement into functional cellular outcomes, accelerating your drug development with physiologically relevant and customized assays.

Service Packages

Our In Vitro Cellular & Signaling Investigation Services provide a suite of targeted assays to quantitatively evaluate drug effects on cellular health, signaling pathways, immune function, and key pathological processes in physiologically relevant models.

In Vitro Cellular Senescence Assessment

We quantify markers of cellular aging, such as SA-β-Gal activity and p16/p21 expression, to evaluate drug-induced senescence. This service supports senolytic drug screening, toxicology studies, and cancer drug resistance research.

In Vitro PARP Inhibition Assessment

We measure a drug's ability to inhibit Poly (ADP-ribose) Polymerase (PARP) activity in live-cell models, often through detection of PAR chain formation or NAD⁺ levels. This is critical for developing PARP inhibitors in oncology and DNA damage response pathways.

In Vitro Cellular Phosphorylation Assessment

We provide high-throughput, multiplexed analysis of drug-induced changes in protein phosphorylation using Western blot, ELISA, and so on. This enables mechanism-of-action validation, kinase inhibitor screening, and detailed signaling pathway mapping.

In Vitro Cell based Phospholipidosis Assessment

We evaluate compounds for their potential to induce phospholipid accumulation in lysosomes, a common side effect of cationic amphiphilic drugs. Using fluorescent probes and high-content imaging, we support early-stage safety and toxicity screening.

Immune Cell Population & Function Analysis

We perform comprehensive immunophenotyping and functional profiling of immune cells (T cells, NK cells, DCs, macrophages) via multicolor flow cytometry, cytokine release assays, and functional readouts. Applications include immuno-oncology, autoimmune disease research, and vaccine development.

In Vitro Cell based α-Synuclein Aggregation Assessment

We monitor and quantify α-synuclein aggregation kinetics in cellular models using high-content imaging, supporting drug discovery for Parkinson's disease and related synucleinopathies.

In Vitro Red Blood Cell Agglutination Assessment

We test drug candidates for hemolytic or agglutination potential on red blood cells, providing essential safety data for injectable biologics, IV formulations, and antibodies targeting RBC surface antigens.

Our Service Process

Required starting materials:

Test Articles: Purified small molecules, monoclonal antibodies, or ADCs.
Project Parameters: Specific target sequences (e.g., for mutated kinases) or desired tissue types (e.g., human primary hepatocytes or iPSC-derived neurons).
Benchmark Data: Previous biochemical IC50 values or safety profiles to assist in dosage range-finding.

Key Steps:

Workflow of In vitro Cellular & Signaling Investigation Services at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables

Quantitative Data Sets: Dose-response curves, IC50/EC50 values, and statistical significance mapping.
High-Resolution Imaging: 3D confocal microscopy images showing drug penetration, target localization, or cellular morphology changes.
Strategic Recommendations: A summary report detailing the implications of the findings for subsequent preclinical or clinical phases.

Key Advantages

Scalable Workflow Integration: We enable seamless progression from small-scale signaling validation to pilot and full-scale efficacy testing across diverse microphysiological platforms.
Precision Cell Line Development: We optimize codon usage and ensure long-term stability of engineered cell lines to achieve consistent, high-level protein expression and reliable signaling outputs.
Tailored Experimental Design: We develop bespoke assays, incorporating mutation-specific models and multi-organ connectivity to ensure services are precisely aligned with your therapeutic focus.

FAQ

Q1: How do you manage non-specific toxicity in cellular assays?
A1: We address this by running parallel cytotoxicity assays, such as LDH release or ATP quantification, in all functional studies. This ensures that observed phenotypic changes are attributable to specific biological mechanisms rather than general cellular damage.
Q2: Can I request a custom phosphorylation assay for a novel kinase target?
A2: Yes, we provide tailored assay development. Our expertise includes creating custom cell models, using CRISPR editing or stable overexpression, to engineer novel target systems. This enables the establishment of specific Western blot, ELISA, or multiplexed assays to measure the activation state of your target.

Why Choose Us?

Our In Vitro Cellular & Signaling Investigation Services deliver precise, mechanism-oriented data for therapeutic development. We perform high-sensitivity quantitative analysis of key signaling pathways, spanning phosphorylation, immune activity, and protein aggregation, using advanced platforms such as high-content imaging and multiplex detection. Our tailored, physiologically aligned assays convert molecular interactions into functional cellular phenotypes, elucidating MOA, confirming target relevance, and expediting progression from discovery to preclinical validation.

How to contact us?

Ready to move beyond target binding and elucidate your compound's functional impact? Contact our expert cell biology team today to discuss how our tailored In vitro Cellular & Signaling Investigation Services can accelerate your therapeutic development.

Reference

Talib, Wamidh H et al. "Targeting Drug Chemo-Resistance in Cancer Using Natural Products." Biomedicines vol. 9,10 1353. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3390/biomedicines9101353.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: